A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma.

Xiaoyun BuLuyao MaShuang LiuDongsheng WenAnna KanYujie XuXuanjia LinMing Shi

Published in: Cancer cell international (2022)

The 50-LPS could not only predict the prognosis of HCC patients robustly and individually, but also provide theoretical basis for therapy. Besides, TDRKH-AS1 was identified as a key lncRNA in the proliferation of HCC. The 50-LPS might guide personalized therapy for HCC patients in clinical practice.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
clinical practice
peritoneal dialysis
prognostic factors
systematic review
signaling pathway
bone marrow
mesenchymal stem cells
cell therapy